Results for this period
Full year1 October 2025 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The healthcare and nursing care cloud platform business reported higher revenue and profit, driven by new customer acquisitions, strong advertising and personnel-matching services, and customized development for major customers. The healthy life expectancy extension business reported higher revenue and profit due to increased use of existing stores, new store openings, higher franchise revenue, and lower store operating costs. The Solutions Development business reported lower revenue and profit due to a review of engineer assignments associated with strengthening AI services and front-loaded costs on certain projects.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025 to 30 September 2026 |
| Net Sales | ¥6,164 million (YoY +12.1%) |
| Operating profit | ¥2,057 million (YoY +28.1%) |
| Ordinary income | ¥2,076 million (YoY +28.8%) |
| Profit attributable to owners of the parent | ¥1,448 million (YoY +30.3%) |
| Net income per share | ¥30.52 |
| Operating Margin | 33.4 |
| Equity ratio | End of the current fiscal period 74.2 / End of previous period 71.1 |
| Total assets | ¥7,804 million |
| Net assets | ¥5,790 million |
| Cash flows from operating activities | ¥2,208 million |
| Cash flows from investing activities | ¥-425 million |
| Cash flows from financing activities | ¥-664 million |
| Cash and cash equivalents at end of period | ¥4,462 million |
| Full-year earnings forecast | Net Sales ¥7,000 million (YoY +13.6%) / Operating profit ¥2,400 million (YoY +16.6%) / Ordinary income ¥2,400 million (YoY +15.6%) / Net income ¥1,600 million (YoY +10.5%) |
| Annual Dividend Forecast | ¥9.5 → ¥10.5（+10.5%） |
| Payout ratio | 31.1 |
| Shareholder Return Policy | For the time being, the company plans to determine the dividend amount based on a payout ratio of at least 30%. |
| Segment revenue | Medical and Nursing Care Cloud Platform Business ¥4,092,501 thousand (YoY +14.2%), Healthy Life Expectancy Extension Business ¥1,390,700 thousand (YoY +17.1%), Solutions Development Business ¥681,337 thousand (YoY -6.7%) |
| Segment profit | Medical and Nursing Care Cloud Platform Business ¥1,930,249 thousand (YoY +28.7%), Healthy Life Expectancy Extension Business ¥221,416 thousand (YoY +41.1%), Solutions Development Business ¥9,709 thousand (YoY -87.5%) |
| Depreciation and amortization | ¥354,159 thousand |
| Impairment loss | No applicable matters |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | Added: 0 companies; removed: 0 companies (company names: —) |
| Material subsequent events | No applicable matters |
| Availability of Supplementary Financial Results Materials | Available |
| Availability of Financial Results Briefing | Yes (for securities analysts and institutional investors) |
| Issued Shares at Period-End | 48,132,000 |
| Treasury Shares at Period-End | 674,706 |
| Factors Behind Changes in Business Performance | The healthcare and nursing care cloud platform business reported higher revenue and profit, driven by new customer acquisitions, strong advertising and personnel-matching services, and customized development for major customers. The healthy life expectancy extension business reported higher revenue and profit due to increased use of existing stores, new store openings, higher franchise revenue, and lower store operating costs. The Solutions Development business reported lower revenue and profit due to a review of engineer assignments associated with strengthening AI services and front-loaded costs on certain projects. |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the healthcare and nursing care cloud business, continued acquisition of new customers, strong platform services, and customized development for major customers contributed to higher revenue. In the healthy life expectancy extension business, increased use of existing stores, new store openings, higher franchise revenue, and lower store operating costs contributed to performance. In contrast, the Solutions Development business reported lower revenue and profit because of a review of engineer assignments to strengthen AI services and front-loaded costs on certain projects.